Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat

Journal of Bone and Mineral Research

Volumn 11, Issue 4, 1996, Pages 430-439

  Mitlak, Bruce H ^a,b   Burdette Miller, Pamela ^a   Schoenfeld, David ^a   Neer, Robert M ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE METABOLISM; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; HORMONE ACTION; NONHUMAN; OSTEOPENIA; RAT;

AMINO ACIDS; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BONE DENSITY; CALCITRIOL; DENSITOMETRY, X-RAY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGENS; FEMALE; FEMUR; HUMANS; OSTEOBLASTS; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PARATHYROID HORMONE; RATS; SPINE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029874050     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110403     Document Type: Article

References (41)

1. Dempster DW, Cosman F. Parisien M, Shen V, Lindsay R 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709.
2. Kimmel DB, Slovik DM, Lane NE 1994 Current and investigational approachs for reversing established osteoporosis. Rheum Dis Clin North Am 20:735-758.
3. Inoue J 1985 Bone changes with long term administration of low dose 1-34 human PTH on adult beagles. J Jpn Ortho Assoc 59:409-427.
4. Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM 1983 Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:1000-1006.
5. Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier, PJ 1991 The in vivo anabolic effect of hPTH(1-34) is blunted when bone resorption is blocked by a bisphosphonate. J Bone Miner Res 6:S136.
6. Li XJ, Stevens M, Mackley KS, Combs D, Tressler J, McOsker J 1994 The ferret: Skeletal responses to treatment with parathyroid hormone. J Bone Miner Res 9:S258.
7. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 280:1340-1344.
8. Slovik DM, Rosenthal DI, Doppelt SH, Potts JT, Daly MA, Campbell JA, Neer RM 1986 Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1:377-381.
9. Neer RM, Slovik DM, Daly M, Potts JT, Nussbaum SR 1993 Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteopor Int 1:204-205.
10. Oxlund H, Ejersted C, Andreassen TT, Torring O, Nilsson MH 1993 Parathyroid hormone (1-34) and (1-84) stimulate coetical bone formation both from periosteum and endosteum. Calcif Tissue Int 1 53:394-399.
11. Ejersted C, Andreassen TT, Oxlund H, Jorgensen PH, Bak B, Haggblad J, Torring O, Nilsson MH 1993 Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:1097-1101.
12. Ejersted C, Andreassen TT, Nilsson MH, Oxlund H 1994 Human parathyroid hormone (1-34) increases bone formation and strength of cortical bone in aged rats. European Journal of Endocrinology 130:201-207.
13. Hefti E, Trechsel U, Bonjour JP, Fleisch H, Schenk R 1982 Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci 62:389-396.
14. Hodsman AB, Steer BM, Fraher LJ, Drost DJ 1991 Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients. Bone Miner 14:67-83.
15. Hesch RD, Heck J, Delling G, Keck E, Reeve J, Canzler H, Schober O, Harms H, Rittinghaus EF 1988 Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38) hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover. Klinische Wochenschrift 66:976-984.
16. Hesch R, Busch U, Prokop M, Delling G, Rittinghaus E 1989 Increase in vertebral density by combination therapy with pulsatile (1-38) hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients. Calc Tissue Int 44:176-180.
17. Mosekilde L, Sogaard CH, Danielsen CC, Torring O 1991 The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). Endocrinology 129:421-428.
18. Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR 1993 The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. Endocrinology 132:1577-1584.
19. Slovik DM, Neer RM, Potts JT 1981 Short-term effects of synthetic human parathyroid hormone-(1-34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 68:1261-1271.
20. Hodsman AB, Fraher LJ 1990 Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients. Bone Miner 9:137-152.
21. Mitlak BH, Williams DC, Bryant HU, Paul DC, Neer RM 1992 Intermittent administration of bovine PTH-(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats. J Bone Miner Res 7:479-484.
22. Abou-Samra AB, Juppner H, Force T, Freeman M, Kong X, Schipani E, Urena P, Richards J, Bonventre J. Potts JT, Kronenberg H, Segre G 1992 Expression cloning of a common receptor for PTH and PTHrP from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Pro Natl Acad Sci 89:2732-2736.
23. Schneider H, Feyen J, Seuwen K, Mowa N 1993 Cloning and functional expression of a human parathyroid hormone receptor. Eur J Pharm 246:149-155.
24. Usdin T, Gruber C, Bonner T 1995 Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270:15455-15458.
25. Hock JM, Gera I 1992 Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7:65-72.
26. Shen V, Dempster DW, Birchman R, Mellish RW, Church E, Kohn D, Lindsay R 1992 Lack of changes in histomorphometric, bone mass, and biochemical parameters in ovariohysterectomized dogs. Bone 13:311-316.
27. Tam CS, Heersche JN, Murray TM, Parsons JA 1982 Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110:506-512.
28. Wronski TJ, Yen CF, Qi H, Dann LM 1993 Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823-831.
29. Finkelstein JS, Klibanski A, Shaefer EH, Hornstein MD, Schiff I, Neer RM 1994 Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331: 1618-1623.
30. Gardella TJ, Rubin D, Abou-Samra AB. Keutmann HT, Potts JT, Kronenberg HM, Nussbaum SR 1990 Expression of human parathyroid hormone-(1-84) in Escherichia coli as a factor X-cleavable fusion protein. J Biol Chem 265:15854-15859.
31. Parsons JA, Reit B, Robinson CJ 1973 A chick bioassay for parathyroid hormone. Endocrinology 92:454-462.
32. Mitlak BH, Schoenfeld D, Neer RM 1994 Accuracy, precision, and utility of spine and whole-skeleton mineral measurements by DXA in rats. J Bone Miner Res 9:119-126.
33. Shen V, Birchman R, Xu R, Lindsay R, Dempster DW 1995 Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen and/or dietary deficient rats. Bone 16:149-156.
34. Kibble R, Vannice J, Bloedow D, Thompson R, Hopfer W, Kung V, Brownfield C, Pacifici R 1994 Interleukin-1 receptor agonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 93:1959-1967.
35. Hollis BW 1986 Assay of circulating 1,25-dihydroxyvitamin D involving a novel single cartridge extraction after purification procedure. Clin Chem 32:2060-2063.
36. Wronski TJ, Dann LM, Scott KS, Cintron M 1989 Long term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45:360-366.
37. Wronski TJ, Yen CF 1994 Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:51-58.
38. Kalu DN, Echon R, Hollis BW 1990 Modulation of ovariectomy-related bone loss by parathyroid hormone in rats. Mechanisms of Ageing & Development 56:49-62.
39. Lindsay R, Cosman F, Shen V, Nieves J, Dempster D 1995 Bone mass increments induced by PTH treatment can be maintained by estrogen. J Bone Miner Res 10:S200.
40. Hodsman A, Fraher L, Adachi J 1995 A clinical trial of cyclical clodronate as mantenance therapy following withdrawal of parathyroid hormone in the treatment of post menopausal osteoporosis. J Bone Miner Res 10:S200.
41. Gunness HM, Gera I, Fonseca J, Raisz LG, Hock JM 1988 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats. Calcif Tissue Inter 43:284-288.